Issuu on Google+


Tuberculosis (TB) is caused by pulmonary Mycobacterium tuberculosis and has infected a third of the world's population, so that is one of the world's problems. Incidence of pulmonary tuberculosis in industrialized countries 40 years show that the prevalence rate is very small. It is estimated there are 8 million people are infected with pulmonary TB 3 million deaths per year and 95%of sufferers in developing countries (WHO,1993). Pulmonary TB in Indonesia according to WHO(1999 and 2004) showed in Indonesia there are 583 000 cases,death is a population of 140,000and 13/100.000new patients. The prevalence of pulmonary TB in 2002 reached 555 000 cases(256 kasus/100.000 population), and 46%of which are new casesor new casesincreased 104/100.000population (Ministry of Health, 2002). Consequencesthat can occur in patients with pulmonary TB who do not take medication, after five years have predicted 50%of patients with pulmonary TB will die. While about 25%will heal itself with high endurance and 25%more as a "chronic cases" who remain infectious (WHO, 1996). Declining quality of human health concerns in the world, WHOfinally declared the end of 1993 global emergency pulmonary TB disease.Concerns and the world's attention increasingly obvious as it appears the epidemic of HIV / AIDS,it is estimated that patients with pulmonary TB is increasing. The drums of war against Mycobacterium tuberculosis germ finally done penanggulang programs, including in Indonesia (Ministry of Health, 2002). Tuberculosis Control (TB) in Indonesia has been going on since Dutch colonial times but are limited to certain groups. After the war of independence, TB addressed through Polyclinics Lung Disease (BP-4). Since 1969 the response made nationally through the Health Center. Anti-tuberculosis (OAT) which is used is the standard alloy INH, PASand Streptomycin for one to two years. The Amino Acid (PAS)is then replaced with Pyrazinamide. Since 1977 began to be used short-term OAT alloy consisting of INH, rifampicin and ethambutol for 6 months. Since 1995, national TB control program began to implement the DOTSstrategy (Directly observed Treatment Short-course) and apply them to health centers gradually. Until 2000, almost all health centers have the commitment and implement the DOTSstrategy to be integrated in primary health care. March 24 is celebrated as World TB Day or World TB Day. This warning is a reminder that TB had been discovered long ago, that is over 100 years ago, medicine has also been found 50 years ago, but the casestill remains a threat to the world. In fact, the world community in 1993 declared TB as an emergency world. World TB Day commemoration (HTBS)this year at the global level the theme of On the Move Against Tuberculosis, Innovate to Accelerate Action to illustrate the need for new innovations to accelerate the strategic efforts against TB. In Indonesia, the theme is translated into the slogan IncreaseInnovation Innovation, Speed of Action against Tuberculosis. Minister dr. Endang Rahayu Sedyaningsih, MPH, Dr.PH said the control of Tuberculosis (TB) in Indonesia has approached the target of the Millennium Development Goals (MDGs). In 2008 the prevalence of TB in Indonesia reaches 253 per 100,000population, while the MDGtarget in 2015 was 222 per 100,000population. Meanwhile, the TB mortality rate in 2008 has dropped sharply to 38 per

100,000population compared to the year 1990 amounting to 92 per 100,000population. That is becausethe implementation of the DOTSstrategy in Indonesia have been carried out extensively with good results. In 2009 the coverage rate reached 71%casedetection and treatment successrate reached 90%. Need the cooperation of various stakeholders in TB control in Indonesia, ranging from medical workers and society in general. Successaccording to the above data needs to be improved in order to reduce the prevalence, incidence and death from TB. Sources: National TB control guidelines of RI Department of Health, 2006. Rusnoto, et al. Factors Associated With Pulmonary TB incidence in Adulthood (The casestudies in Central Pulmonary DiseasePrevention and Treatment of Starch)


One Heart for TB